Treatmybrand


a Kainjoo SA Venture
Ch. du Vernay 14a
1196 Gland
+41.21.561.34.96
[email protected]

Support


Monday to Friday
8AM to 8PM
[email protected]
Back

Intellia Therapeutics Halts Late-Stage CRISPR Trials Following Patient Safety Issue

Intellia Therapeutics has announced a pause in two of its advanced CRISPR gene-editing clinical trials after a patient involved in one trial experienced liver damage that required hospitalization.

Stat
Stat